Lawyers for SAC Capital put a jolt into the SEC when they said accused trader Mathew Martoma had no short positions on two drug stocks and did not profit from them
In his bitter goodbye to the firm he once loved, the former Goldman employee discovers the truth: You are what you earn, and the client will never matter more than that